New Biologic Tulisokibart Beats Placebo in UC Trial ...Middle East

Medscape - News
The experimental monoclonal antibody tulisokibart safely induced clinical remission in a phase 2 randomized trial of moderately to severely active ulcerative colitis. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( New Biologic Tulisokibart Beats Placebo in UC Trial )

Apple Storegoogle play

Also on site :

Most viewed in News